A carregar...

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.

Altogether 117 patients with advanced breast cancer were treated with either tamoxifen 10 mg by mouth twice daily or aminoglutethimide 250 mg by mouth four times daily with hydrocortisone 20 mg twice daily in a randomised cross-over trial in which patients who failed to respond to the first treatmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smith, I E, Harris, A L, Morgan, M, Ford, H T, Gazet, J C, Harmer, C L, White, H, Parsons, C A, Villardo, A, Walsh, G, McKinna, J A
Formato: Artigo
Idioma:Inglês
Publicado em: 1981
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1507612/
https://ncbi.nlm.nih.gov/pubmed/6797571
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!